Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase

J Neurol Sci. 2003 Apr 15;208(1-2):51-6. doi: 10.1016/s0022-510x(02)00423-9.

Abstract

Anti-glutamate decarboxylase autoantibodies (GAD-A) are associated with a group of patients with progressive cerebellar ataxia. We reported previously that cerebellar GABA(A)-mediated synaptic transmission was presynaptically depressed by GAD-A in the cerebrospinal fluid (CSF). Using whole-cell recording of rat cerebellar slices, we found in the present study that CSF immunoglobulins from ataxic patients reduced gamma-aminobutyric acid (GABA) release from cerebellar interneurons, thereby attenuating presynaptic inhibition on neighboring excitatory synapses through GABA(B) receptors (GABA(B)Rs). Our results suggest that in in vitro slices, GAD-A elicited the pathophysiological action of reduction in GABA release, which subsequently resulted in dual synaptic impairment in the cerebellar circuit, by depression of GABA(A) receptor (GABA(A)R)-mediated inhibitory synaptic transmissions, and attenuation of GABA(B) receptor-mediated inhibition of excitatory transmissions.

Publication types

  • Comparative Study

MeSH terms

  • Action Potentials / drug effects
  • Aged
  • Animals
  • Autoantibodies / pharmacology*
  • Baclofen / pharmacology
  • Cerebellar Ataxia / immunology
  • Cerebellar Cortex / cytology
  • Cerebellar Cortex / drug effects
  • Cerebellar Cortex / physiology
  • Electric Stimulation
  • Excitatory Postsynaptic Potentials / drug effects
  • Female
  • GABA Agonists / pharmacology
  • Glutamate Decarboxylase / immunology*
  • Glutamate Decarboxylase / pharmacology
  • Humans
  • Immunoglobulin G / pharmacology
  • In Vitro Techniques
  • Neural Inhibition / drug effects
  • Neurons / drug effects
  • Neurons / physiology
  • Patch-Clamp Techniques / methods
  • Rats
  • Receptors, GABA-A / physiology*
  • Receptors, GABA-B / physiology*
  • Synapses / drug effects*

Substances

  • Autoantibodies
  • GABA Agonists
  • Immunoglobulin G
  • Receptors, GABA-A
  • Receptors, GABA-B
  • Glutamate Decarboxylase
  • Baclofen